163217-70-7 Usage
Uses
Used in Pharmaceutical Industry:
P-HYDROXY ATORVASTATIN LACTONE is used as a therapeutic agent for the treatment of hypercholesterolemia. It functions by lowering elevated levels of LDL-cholesterol and triglycerides in patients, thus helping to manage and reduce the risk of cardiovascular diseases.
Used in Research and Development:
As a metabolite of Atorvastatin, P-HYDROXY ATORVASTATIN LACTONE is also used in research and development for further understanding the mechanisms of action, pharmacokinetics, and potential applications in the treatment of other related conditions. This can lead to the development of new drugs or improved drug formulations with enhanced efficacy and safety profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 163217-70-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,3,2,1 and 7 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 163217-70:
(8*1)+(7*6)+(6*3)+(5*2)+(4*1)+(3*7)+(2*7)+(1*0)=117
117 % 10 = 7
So 163217-70-7 is a valid CAS Registry Number.
163217-70-7Relevant articles and documents
Synthesis of deuterium-labeled atorvastatin and its metabolites for use as internal standards in a LC/MS/MS method developed for quantitation of the drug and its metabolites in human serum
Chen, Bang-Chi,Sundeen, Joseph E.,Guo, Peng,Bednarz, Mark S.,Hangeland, Jon J.,Ahmed, Syed Z.,Jemal, Mohammed
, p. 261 - 270 (2007/10/03)
D5-labeled isotopomers of atorvastatin, atorvastatin lactone and its hydroxy metabolites were synthesized as internal standards for use in a LC/MS/MS method developed for the simultaneous quantitative determination of atorvastatin and its hydroxy metabolites in human serum. d5-Atorvastatin and d5-atorvastatin lactone were prepared from d5-aniline whereas their corresponding hydroxy metabolites were synthesized using d5-benzaldehyde.
[(Hydroxyphenylamino) carbonyl] pyrroles
-
, (2008/06/13)
2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(hydroxyphenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid, and their lactone forms, and salts and solyates thereof, inhibit cholesterol biosynthesis, and thus are useful in treating hyperchole